Results 231 to 240 of about 8,564,356 (290)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto, Dariia Kliushnikova, Richard Friedrich Radlberger, Sinan Yasaroglu, Tobias Moser, Andrea Harrer, Kitty Kratzer, Wolfgang Hitzl, Christiane Gradl, Martin Schmidauer, Patrick Roth, Harald Hegen, Peter Wipfler   +12 more
wiley   +1 more source

HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with <i>de novo</i> donor-specific antibodies. [PDF]

Front Immunol
Béland MA, Lapointe I, Côté I, Lesage J, Houde I, Wagner E, Riopel J, Latulippe E, Désy O, De Serres SA.   +9 more
europepmc   +1 more source

Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF312

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Intracerebral hemorrhage (ICH) causes high morbidity and mortality, with neurotoxic inflammation driven by infiltrating monocytes. This study is an in‐depth longitudinal examination of the immune response during the first week of ICH in the presence and absence of the immunomodulatory drug BAF312 (Siponimod).
Jonathan Howard DeLong, Sebastian Díaz‐Pérez, Kevin Navin Sheth, Jang‐Ho Cha, C. J. Malanga, Patricia G. M. Wagner, Nicole Pezous, Aurelie Hanin, Kyle B. Walsh, H. E. Hinson, Lauren Hachmann Sansing   +10 more
wiley   +1 more source

Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch Methods. [PDF]

Transplant Direct
Ziemann M, Lindemann M, Hallensleben M, Altermann W, Althaus K, Budde K, Einecke G, Eisenberger U, Ender A, Feldkamp T, Grahammer F, Guthoff M, Holzmann-Littig C, Hugo C, Kauke T, Kemmner S, Koch M, Lachmann N, Marget M, Morath C, Nitschke M, Renders L, Scherer S, Stumpf J, Schwenger V, Sommer F, Spriewald B, Süsal C, Zecher D, Heinemann FM, Verboom M.   +30 more
europepmc   +1 more source

Assessing the Predictive Power of PIRCHE-II Scores for the Development of <i>De Novo</i> Donor-Specific Antibodies After Simultaneous Pancreas-Kidney Transplantation. [PDF]

Transpl Int
Raineri F, Frischknecht L, Nilsson J, Rössler F, Cavelti-Weder C, von Moos S, Schachtner T.   +6 more
europepmc   +1 more source

Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation. [PDF]

Microorganisms
Cioni M, Muscianisi S, De Cicco M, Basso S, Hirsch HH, Fontana I, Catenacci L, Bagnarino J, Siciliano M, Montana Lampo O, Acquafredda G, Boti LTD, Rotella J, Bozza E, Zumelli J, Mebelli K, Baldanti F, Cardillo M, Zecca M, Nocera A, Luppi M, Verrina E, Ginevri F, Comoli P.   +23 more
europepmc   +1 more source

The Combination of Intravenous Immunoglobulin, Dexamethasone, and a High Dose of Mononuclear Cells Transfusion: An Effective Strategy for Decreasing Donor-Specific Antibodies During Haploidentical Hematopoietic Stem Cell Transplantation. [PDF]

Cell Transplant
Li X, Li Y, Zhang D, Hu X, Liu L, Yuan Z, Li S, Dong Y, Chen Y, Wang S.   +9 more
europepmc   +1 more source

Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study. [PDF]

BMC Nephrol
Guo Z, Sa R, Zhao D, Li S, Guo H, Zhu L, Chen G.   +6 more
europepmc   +1 more source

Absence of IL-6 Receptor Blockade Effect on the Outcomes of Transplant Glomerulopathy in the Absence of Anti-HLA Donor-specific Antibodies. [PDF]

Transplant Direct
Mella A, Lavacca A, Dodoi DT, Presta R, Fop F, Campagna M, Manzione AM, Dolla C, Gallo E, Abbasciano I, Gai C, Camussi G, Barreca A, Caorsi C, Giovinazzo G, Biancone L.   +15 more
europepmc   +1 more source